Life ScienceCompany
Supernus Pharmaceuticals M&A Summary
Supernus Pharmaceuticals has acquired 3 companies, including 2 in the last 5 years.
Supernus Pharmaceuticals’ largest acquisition to date was in 2021, when it acquired Adamas Pharmaceuticals for $450M. Supernus Pharmaceuticals has acquired in 3 different US states. The Company’s most targeted sectors include life science (100%).
Supernus Pharmaceuticals Business Overview
Where is Supernus Pharmaceuticals headquartered?
Supernus Pharmaceuticals is headquartered in Rockville, Maryland.
What is Supernus Pharmaceuticals’ revenue?
Supernus Pharmaceuticals disclosed revenue of 608M USD for 2023 and 667M USD for 2022.
How many employees does Supernus Pharmaceuticals have?
Supernus Pharmaceuticals has 652 employees.
What sector is Supernus Pharmaceuticals in?
Supernus Pharmaceuticals is a life science company.
When was Supernus Pharmaceuticals founded?
Supernus Pharmaceuticals was founded in 2005.
M&A Summary
-
M&A Total Activity3
- M&A Buy Activity3
- Total Sectors Invested 1
- Total Countries Invested 1
- M&A Buy/Sell Connections 1
- M&A Advisors 2
Unlimited Searches
